Marksans Pharma gets final USFDA nod for generic version of Famotidine tablets

Marksans Pharma Ltd on Friday said it has received final approval from the US health regulator for its generic version of Famotidine tablets indicated for the treatment of acid indigestion and heartburn.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news